Janus Pharmaceuticals Inc. focuses on identifying, acquiring, and aggressively developing prescription products for the treatment of skin infections. The company has a strong intellectual property portfolio for topical anti-infective compounds and aims to rapidly bring these products to market through fast regulatory pathways. With a management team and board located in the US and Japan, Janus has a trans-Pacific network and resources in the biopharmaceutical industry. The company offers antifungal and antibiotic drugs, serving customers in North America, Europe, and South America. Founded in 2004 and based in Pasadena, California, Janus Pharmaceuticals operates in the United States and Japan.